publication venue for
- Comparing the clinical trial efficacy versus real-world effectiveness of treatments for multiple myeloma: a population-based study. 2024
- Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study. 108:3384-3391. 2023
- High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes. 108:532-542. 2023
- Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy. 107:1219-1221. 2022
- Symptom burden in transplant-ineligible patients with newly diagnosed multiple myeloma: a population-based cohort study. 106:1991-1994. 2021
- Humanized zebrafish enhance human hematopoietic stem cell survival and promote acute myeloid leukemia clonal diversity. 105:2391-2399. 2019
- Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study. 104:e474-e477. 2019
- T-cell large granular lymphocytic leukemia and plasma cell disorders. 104:e108-e110. 2019
- Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study. 104:e51-e53. 2019
- Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells. 104:82-92. 2019
- Loss of DEP-1 (Ptprj) promotes myeloproliferative disease in FLT3-ITD acute myeloid leukemia. 103:e505-e509. 2018
- GFI1 is required for RUNX1/ETO positive acute myeloid leukemia. 103:e395-e399. 2018
- Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation. 103:1229-1234. 2018
- Iron overload in transfusion-dependent survivors of hemoglobin Bart’s hydrops fetalis. 103:e184-e187. 2018
- CD56 bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft- versus -host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results. 102:1936-1946. 2017
- Hb S/ +-thalassemia due to Hb sickle and a novel deletion of DNase I hypersensitive sites HS3 and HS4 of the locus control region. 100:e166-e168. 2015
- The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes. 100:633-642. 2015
- Thrombosis is associated with inferior survival in multiple myeloma. 97:1603-1607. 2012
- Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded. 97:1507-1513. 2012
- Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. 95:1952-1959. 2010
- Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. 94:850-856. 2009
- Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO. 93:1728-1733. 2008
- Variability of clinical manifestation of factor VII-deficiency in homozygous and heterozygous subjects of the European F7 gene mutation A294V. 93:1273-1275. 2008
- Inflammation and oxidant-stress in -thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. 93:817-825. 2008
- SBDS-deficient cells undergo accelerated apoptosis through the Fas-pathway. 93:363-371. 2008
- Acute pancreatitis preceding thrombotic thrombocytopenic Purpura. 92:e94-e95. 2007
- Hb Evora [ 2 35, Ser->Pro], a novel hemoglobin variant associated with an -thalassemia phenotype. 92:e68-e68. 2007
- The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia.. 91:1530-1537. 2006
- High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C.. 91:1367-1371. 2006
- Safety of dalteparin for the prophylaxis of venous thromboembolism in elderly medical patients with renal insufficiency: a pilot study.. 91:976-979. 2006
- Determining the cause of patchwork HBA1 and HBA2 genes: recurrent gene conversion or crossing over fixation events.. 91:297-302. 2006
- Home-treatment of deep vein thrombosis in patients with cancer.. 90:150. 2005
- Identification of growth factor conditions that reduce ex vivo cord blood progenitor expansion but do not alter human repopulating cell function in vivo.. 90:166-172. 2005
- Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.. 90:137-139. 2005
- Thromboprophylaxis practice patterns in two Western Australian teaching hospitals.. 89:586-593. 2004
- SDF-1 enhances the expansion and maintenance of highly purified human hematopoietic progenitors. 4:137-145. 2003
- Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia.. 87:948-956. 2002
- Selecting patients for home treatment of deep vein thrombosis: the problem of cancer.. 87:286-291. 2002
- Experiences of a low-intensity anticoagulation regimen for extended secondary prevention of venous thromboembolism. 3:311-314. 2002
- Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success.. 86:1186-1193. 2001
- Overview of the clinical results of pentasaccharide in major orthopedic surgery.. 86:59-62. 2001
- IgG subclasses on the lymphocyte surface in chronic lymphocytic leukemia (CLL).. 70:75-77. 1985